Popular Filters
Trials for Cytomegalovirus Infection Patients
Cancer Vaccine
CMV Vaccine for Cytomegalovirus
Recruiting0 awardsPhase 1 & 2
Galveston, Texas
This trial is testing a new CMV vaccine in healthy adults aged 18 to 50. The vaccine uses parts of the CMV virus to help the immune system recognize and fight it. The study will check if the vaccine is safe and effective. Live CMV vaccines in healthy adults have been shown to be safe and to induce immune responses similar to those that occur with natural CMV infection.
Virus Therapy
Virus-Specific T-Cell Therapy for Infections
Recruiting1 awardPhase 1 & 2
Pittsburgh, Pennsylvania
This trial tests special immune cells designed to fight specific viruses in patients with weak immune systems or those who have had transplants. These patients have infections that don't respond to regular treatments. The donor immune cells help attack the viruses in their bodies. This approach has shown promise in enhancing immune responses to viruses like CMV and EBV.
Trials for Chronic Lymphocytic Leukemia Patients
Virus Therapy
CMV-Specific T-Cells for Cytomegalovirus Infection
Recruiting1 awardPhase 2
Houston, Texas
This trial looks at whether white blood cells from donors who have been exposed to cytomegalovirus can help treat patients with a cytomegalovirus infection that has come back or has not gotten better despite standard therapy.
Antiviral
Letermovir for Preventing Infection After Stem Cell Transplant in Blood Cancer
Recruiting2 awardsPhase 3
New Orleans, Louisiana
"This trial aims to see if giving letermovir before stem cell transplant can help reduce the chances of getting a virus called cytomegalovirus in children and teenagers. The treatments before a stem
Trials With No Placebo
Virus Therapy
HLA-matched VSTs for Viral Infections Post Stem Cell Transplant
Recruiting1 awardPhase 1
Houston, Texas
This trial is for patients who have had a stem cell transplant and have developed a viral infection that is not responding to standard therapy. In this trial, the patient will receive white blood cells that have been specially trained to fight the viral infection.
CAR T-cell Therapy
Adoptive Immunotherapy for Viral Infections
Recruiting1 awardPhase 1 & 2
Washington, District of Columbia
This trial is a Phase I-II dose-finding trial to determine the optimal dose of intravenous injection of donor-derived cytotoxic T lymphocytes specific for CMV, EBV, BKV, and Adenovirus.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.